Search

everythinglearnresearchcommunity

for

Search:↓

Activating STAT5 in the skin's dermal papilla is key for starting hair growth, regenerating hair follicles, and healing wounds.

Vitamin D might help treat alopecia areata.

People with certain skin diseases have higher levels of the hormone prolactin in their blood.

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

The document discusses various diseases of the outer ear, categorized by symptoms like redness, crusts, bumps, pus-filled lesions, lumps, ulcers, and hair loss.

The meeting presented new findings on hair stem cells, pigmentation, genetics, and modern hair treatment techniques.

A new one-step test can quickly identify skin cancer during surgery.

Topical glucocorticoids thin the skin and change collagen structure.

Pregnancy can trigger follicular mucinosis, which may resolve after delivery.

Endocrine-disrupting chemicals cause irreversible harm to children's development, increasing disease risk.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Upadacitinib improved multiple immune-related conditions in one patient.

Higher IL-17A and IL-23 levels are linked to alopecia areata severity and could help in tracking and treating the disease.

Ustekinumab and vedolizumab can help some ulcerative colitis patients with hair regrowth, but results vary.

Tattoos may trigger autoimmune symptoms in some people.

Platelet-rich plasma might help treat eczema by reducing inflammation and repairing the skin.

Targeting specific cell interactions may help treat skin fibrosis.

Bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata may share immune-related causes.

Baricitinib treatment for alopecia universalis can cause hair regrowth with unexpected whitening.

Higher levels of IL-17A and IL-2 are linked to alopecia areata.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

New treatments offer hope for better managing hidradenitis suppurativa.

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.

Topical corticosteroids are the preferred first treatment for children with Alopecia Areata.

Prolactin levels and gene polymorphism are not linked to vitiligo severity but are related to BMI.

Cells can change to help heal wounds better.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

Mint water extract boosts protective enzymes in skin cells.

Claudin-1 and Claudin-3 are crucial for keeping hair follicle structure and preventing a type of hair loss called telogen effluvium.